Online first
Original article
Published online: 2024-10-25
Iron level and vulnerable coronary atherosclerotic plaques
Abstract
Not available
References
- Sullivan JL. Iron and the sex difference in heart disease risk. Lancet. 1981; 1(8233): 1293–1294.
- Wunderer F, Traeger L, Sigurslid HH, et al. The role of hepcidin and iron homeostasis in atherosclerosis. Pharmacol Res. 2020; 153: 104664.
- Bagheri B, Shokrzadeh M, Mokhberi V, et al. Association between serum iron and the severity of coronary artery disease. Int Cardiovasc Res J. 2013; 7(3): 95–98.
- Vinchi F, Porto G, Simmelbauer A, et al. Atherosclerosis is aggravated by iron overload and ameliorated by dietary and pharmacological iron restriction. Eur Heart J. 2020; 41(28): 2681–2695.
- Salonen JT, Nyyssönen K, Korpela H, et al. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation. 1992; 86(3): 803–811.
- von Haehling S, Jankowska EA, van Veldhuisen DJ, et al. Iron deficiency and cardiovascular disease. Nat Rev Cardiol. 2015; 12(11): 659–669.
- Cornelissen A, Guo L, Sakamoto A, et al. New insights into the role of iron in inflammation and atherosclerosis. EBioMedicine. 2019; 47: 598–606.
- Anderson GJ, Frazer DM. Current understanding of iron homeostasis. Am J Clin Nutr. 2017; 106(Suppl 6): 1559S–1566S.
- Oleksiak A, Kępka C, Kruk M. The relationship between anisocytosis, quantitative and qualitative characteristics of coronary atherosclerosis, and major adverse cardiac events in patients with coronary artery disease: Rationale and study design. Kardiol Pol. 2022; 80(6): 699–701.
- Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013; 34(38): 2949–3003.
- Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020; 41(3): 407–477.
- Maurovich-Horvat P, Ferencik M, Voros S, et al. Comprehensive plaque assessment by coronary CT angiography. Nat Rev Cardiol. 2014; 11(7): 390–402.
- Bom MJ, van der Heijden DJ, Kedhi E, et al. Early detection and treatment of the vulnerable coronary plaque: Can we prevent acute coronary syndromes? Circ Cardiovasc Imaging. 2017; 10(5): e005973.
- Nerlekar N, Ha FJ, Cheshire C, et al. Computed tomographic coronary angiography-derived plaque characteristics predict major adverse cardiovascular events: A systematic review and meta-analysis. Circ Cardiovasc Imaging. 2018; 11(1): e006973.
- Lee SE, Chang HJ, Sung JiM, et al. Effects of statins on coronary atherosclerotic plaques: the PARADIGM study. JACC Cardiovasc Imaging. 2018; 11(10): 1475–1484.
- Puchner SB, Liu T, Mayrhofer T, et al. High-risk plaque detected on coronary CT angiography predicts acute coronary syndromes independent of significant stenosis in acute chest pain: Results from the ROMICAT-II trial. J Am Coll Cardiol. 2014; 64(7): 684–692.
- Henzel J, Kępka C, Kruk M, et al. High-risk coronary plaque regression after intensive lifestyle intervention in nonobstructive coronary disease: A randomized study. JACC Cardiovasc Imaging. 2021; 14(6): 1192–1202.
- Oleksiak A, Kruk M, Rucinska KI, et al. Blood iron level and vulnerable coronary atherosclerotic plaques. Eur Heart J Acute Cardiovasc Care. 2021; 10(Suppl 1): zuab020.058.
- Gustafsson H, Hallbeck M, Norell M, et al. Fe(III) distribution varies substantially within and between atherosclerotic plaques. Magn Reson Med. 2014; 71(2): 885–892.
- Jenča D, Melenovský V, Mrázková J, et al. Iron deficiency and all-cause mortality after myocardial infarction. Eur J Intern Med. 2024; 126: 102–108.
- Williams MC, Kwiecinski J, Doris M, et al. Low-attenuation noncalcified plaque on coronary computed tomography angiography predicts myocardial infarction: Results from the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART). Circulation. 2020; 141(18): 1452–1462.
- Ozaki Y, Okumura M, Ismail TF, et al. Coronary CT angiographic characteristics of culprit lesions in acute coronary syndromes not related to plaque rupture as defined by optical coherence tomography and angioscopy. Eur Heart J. 2011; 32(22): 2814–2823.
- Boogers MJ, Broersen A, van Velzen JE, et al. Automated quantification of coronary plaque with computed tomography: Comparison with intravascular ultrasound using a dedicated registration algorithm for fusion-based quantification. Eur Heart J. 2012; 33(8): 1007–1016.
- Dey D, Schepis T, Marwan M, et al. Automated three-dimensional quantification of noncalcified coronary plaque from coronary CT angiography: Comparison with intravascular US. Radiology. 2010; 257(2): 516–522.
- Kraml PJ, Klein RL, Huang Y, et al. Iron loading increases cholesterol accumulation and macrophage scavenger receptor I expression in THP-1 mononuclear phagocytes. Metabolism. 2005; 54(4): 453–459.
- Lapenna D, Pierdomenico SD, Ciofani G, et al. Association of body iron stores with low molecular weight iron and oxidant damage of human atherosclerotic plaques. Free Radic Biol Med. 2007; 42(4): 492–498.
- Tuomainen TP, Loft S, Nyyssönen K, et al. Body iron is a contributor to oxidative damage of DNA. Free Radic Res. 2007; 41(3): 324–328.
- Sakakura K, Nakano M, Otsuka F, et al. Pathophysiology of atherosclerosis plaque progression. Heart Lung Circ. 2013; 22(6): 399–411.
- Leitinger N, Schulman IG. Phenotypic polarization of macrophages in atherosclerosis. Arterioscler Thromb Vasc Biol. 2013; 33(6): 1120–1126.
- Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: A dynamic balance. Nat Rev Immunol. 2013; 13(10): 709–721.
- Stöger JL, Gijbels MJJ, van der Velden S, et al. Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis. 2012; 225(2): 461–468.
